Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,899.00    -1.00 (-0.05%)
Bid:
1,905.00
Ask:
1,908.00
Spread: 3.00 (0.157%)
Market Cap: £2.12b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Lettings

21 Jul 2008 07:30

RNS Number : 4583Z
Derwent London PLC
21 July 2008
 



3PRESS RELEASE

21 July 2008

Derwent London plc ("Derwent London" / "Company")

DERWENT LONDON PRE-LETS TO CANCER RESEARCH uk 

140,000 SQ FT OFFICEAT aNGEL BUILDINGLONDON EC1

Derwent London has agreed a letting with Cancer Research UK ("CR-UK"), one of the UK's leading charities. This will result in over 50% of the Angel Building being pre-let prior to the completion of its reconstruction in mid 2010.

CR-UK is taking the ground, first, second and part-third floors, comprising 139,500 sq ft (12,960 sq m) of the 263,000 sq ft (24,433 sq m) building on a 20 year lease, with a break at the 15th year, at a rent of £5,613,311 per annum, representing a rent of £41.00 per sq ft on the first, second and part-third floors and £35.00 per sq ft at ground floor. There is a rent-free period of 24 months and a six month penalty if the break option is exercised.  Until practical completion CR-UK has the right to take the remaining 28,804 sq ft / 2,676 sq m of the third floor at a rent of £41.00 per sq ft or to exclude the entire third floor from its occupancy.

Situated in Clerkenwell on the corner of Pentonville Road and St. John Street and immediately south of Angel tube station, the building is within walking distance of Kings Cross and the newly opened St Pancras Eurostar terminal. The scheme will include 13,500 sq ft (1,254 sq m) of ground floor retail, a full height 9,500 sq ft (882 sq m) atrium reception area on a 0.31 acre (0.035 hectare) island site.

Formerly known as the Angel Centre, Derwent acquired the building through its merger with London Merchant Securities ("LMS") in February 2007 and immediately instigated a strategy to progress total refurbishment. This included agreeing lease surrender with the tenant, who continues to pay a rent of £4.3m per annum until March 2010. In February this year, Derwent secured planning permission for the Allford Hall Monaghan Morris redesign of the building which will add c.101,000 sq ft net (9,383 sq m) of new floor area to the original building.

-ends-

For further information please contact:

Dido Laurimore/ Olivia Goodall, Financial Dynamics (for Derwent London): Tel: 020 7831 3113

John Burns, Chief Executive, Derwent London: Tel 020 7659 3000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDRCSBGGII
Date   Source Headline
2nd Sep 202511:30 amRNSHolding(s) in Company
29th Aug 20254:45 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNSBoard Change
12th Aug 20257:00 amRNSInterim Results
5th Aug 20257:00 amRNSNew headlease agreed at 50 Baker Street W1
31st Jul 20254:45 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSDisposal of Francis House SW1 for £55.5m
25th Jul 20257:00 amRNSExtension of £450m Revolving Credit Facility
30th Jun 20254:45 pmRNSTotal Voting Rights
18th Jun 20257:00 amRNSAdobe lease extension and expansion
12th Jun 202511:00 amRNSRedemption of £175 million Convertible Bonds
30th May 20254:45 pmRNSTotal Voting Rights
29th May 202511:15 amRNSHolding(s) in Company
23rd May 20254:05 pmRNS£250m 7-year 5.25% bond issuance
16th May 202512:00 pmRNSResults of 2025 Annual General Meeting
8th May 20257:00 amRNSFirst Quarter Business Update
1st May 202510:00 amRNSAnnual Bondholder Meeting
30th Apr 20254:45 pmRNSTotal Voting Rights
15th Apr 202510:00 amRNSAnnual Financial Report
9th Apr 20253:00 pmRNSAdditional Listing
31st Mar 20254:45 pmRNSTotal Voting Rights
31st Mar 202510:00 amRNSNotice of Q1 2025 Business Update
26th Mar 20251:00 pmRNSDirector/PDMR Shareholding
20th Mar 20254:45 pmRNSBlock listing Interim Review
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
4th Mar 20255:15 pmRNSDirector/PDMR Shareholding
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSResults for the Year Ended 31 December 2024
31st Jan 20254:45 pmRNSTotal Voting Rights
30th Jan 20255:35 pmRNSHolding(s) in Company
27th Jan 20251:30 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS25 Baker Street W1 offices fully pre-let
31st Dec 202412:45 pmRNSTotal Voting Rights
3rd Dec 20247:00 amRNSAcquisition
29th Nov 20244:45 pmRNSTotal Voting Rights
7th Nov 20247:00 amRNSTHIRD QUARTER BUSINESS UPDATE
5th Nov 202412:44 pmRNSHolding(s) in Company
31st Oct 20244:45 pmRNSTotal Voting Rights
23rd Oct 20245:30 pmRNSHolding(s) in Company
16th Oct 202410:30 amRNSDirectorate Change
30th Sep 20244:45 pmRNSTotal Voting Rights
20th Sep 20244:45 pmRNSBlock listing Interim Review
19th Sep 202411:00 amRNSDirector/PDMR Shareholding
17th Sep 202411:03 amRNSHolding(s) in Company
30th Aug 20244:45 pmRNSTotal Voting Rights
23rd Aug 202411:15 amRNSAdditional Listing
8th Aug 20247:00 amRNSHalf-Year Results
31st Jul 20244:45 pmRNSTotal Voting Rights
28th Jun 20244:45 pmRNSTotal Voting Rights
12th Jun 202411:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.